L-Selenomethionine Does Not Protect Against Testosterone Plus 17β-Estradiol-Induced Oxidative Stress and Preneoplastic Lesions in the Prostate of NBL Rats

REFERENCES

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al.: Global cancer statistics. CA Cancer J Clin 61, 69–90, 2011.
   PubMed Web of Science ®Google Scholar
• Bosland MC, McCormick DL, Melamed J, Walden PD, Zeleniuch-Jacquotte A, et al.: Chemoprevention strategies for prostate cancer. Eur J Cancer Prev 11(Suppl 2), S18–27, 2002.
   PubMed Web of Science ®Google Scholar
• De Marzo AM, Platz EA, Sutcliffe S, Xu J, Gronberg H, et al.: Inflammation in prostate carcinogenesis. Nat Rev Cancer 7, 256–269, 2007.
   PubMed Web of Science ®Google Scholar
• Palapattu GS, Sutcliffe S, Bastian PJ, Platz EA, De Marzo AM, et al.: Prostate carcinogenesis and inflammation: emerging insights. Carcinogenesis 26, 1170–1181, 2005.
   PubMed Web of Science ®Google Scholar
• Chen L, Stacewicz-Sapuntzakis M, Duncan C, Sharifi R, Ghosh L, et al.: Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention. J Natl Cancer Inst 93, 1872–1879, 2001.
   PubMed Web of Science ®Google Scholar
• Combs GF, Jr., and Gray WP: Chemopreventive agents: selenium. Pharmacol Ther 79, 179–192, 1998.
   PubMed Web of Science ®Google Scholar
• Allan CB, Lacourciere GM, and Stadtman TC: Responsiveness of selenoproteins to dietary selenium. Annu Rev Nutr 19, 1–16, 1999.
   PubMed Web of Science ®Google Scholar
• Kandas NO, Randolph C, and Bosland MC: Differential effects of selenium on benign and malignant prostate epithelial cells: stimulation of LNCaP cell growth by noncytotoxic, low selenite concentrations. Nutr Cancer 61, 251–264, 2009.
   PubMed Web of Science ®Google Scholar
• Hurst R, Hooper L, Norat T, Lau R, Aune D, et al.: Selenium and prostate cancer: systematic review and meta-analysis. Am J Clin Nutr 96, 111–122, 2012.
   PubMed Web of Science ®Google Scholar
• Jiang L, Yang KH, Tian JH, Guan QL, Yao N, et al.: Efficacy of antioxidant vitamins and selenium supplement in prostate cancer prevention: a meta-analysis of randomized controlled trials. Nutr Cancer 62, 719–727, 2010.
   PubMed Web of Science ®Google Scholar
• Etminan M, FitzGerald JM, Gleave M, and Chambers K: Intake of selenium in the prevention of prostate cancer: a systematic review and meta-analysis. Cancer Causes Control 16, 1125–1131, 2005.
   PubMed Web of Science ®Google Scholar
• Stratton J, and Godwin M: The effect of supplemental vitamins and minerals on the development of prostate cancer: a systematic review and meta-analysis. Fam Pract 28, 243–252, 2011.
   PubMed Web of Science ®Google Scholar
• Clark LC, Dalkin B, Krongrad A, Combs GF, Jr., Turnbull BW, et al.: Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol 81, 730–734, 1998.
   PubMedGoogle Scholar
• Duffield-Lillico AJ, Dalkin BL, Reid ME, Turnbull BW, Slate EH, et al.: Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU Int 91, 608–612, 2003.
   PubMed Web of Science ®Google Scholar
• Algotar AM, Stratton MS, Ahmann FR, Ranger-Moore J, Nagle RB, et al.: Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer. Prostate 73, 328–335, 2013.
   PubMed Web of Science ®Google Scholar
• Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, et al.: Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301, 39–51, 2009.
   PubMed Web of Science ®Google Scholar
• Marshall JR, Tangen CM, Sakr WA, Wood DP, Jr., Berry DL, et al.: Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917. Cancer Prev Res (Phila) 4, 1761–1769, 2011.
   PubMed Web of Science ®Google Scholar
• McCormick DL, Rao KV, Johnson WD, Bosland MC, Lubet RA, et al.: Null activity of selenium and vitamin e as cancer chemopreventive agents in the rat prostate. Cancer Prev Res (Phila) 3, 381–392, 2010.
   PubMed Web of Science ®Google Scholar
• Nakamura A, Shirai T, Takahashi S, Ogawa K, Hirose M, et al.: Lack of modification by naturally occurring antioxidants of 3,2’-dimethyl-4-aminobiphenyl-initiated rat prostate carcinogenesis. Cancer Lett 58, 241–246, 1991.
   PubMed Web of Science ®Google Scholar
• Li GX, Lee HJ, Wang Z, Hu H, Liao JD, et al.: Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite. Carcinogenesis 29, 1005–1012, 2008.
   PubMed Web of Science ®Google Scholar
• Lindshield BL, Ford NA, Canene-Adams K, Diamond AM, Wallig MA, et al.: Selenium, but not lycopene or vitamin E, decreases growth of transplantable dunning R3327-H rat prostate tumors. PLoS One 5, e10423, 2010.
   PubMed Web of Science ®Google Scholar
• Wang L, Bonorden MJ, Li GX, Lee HJ, Hu H, et al.: Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit. Cancer Prev Res (Phila) 2, 484–495, 2009.
   PubMed Web of Science ®Google Scholar
• Ozten N, Horton L, Lasano S, and Bosland MC: Selenomethionine and alpha-tocopherol do not inhibit prostate carcinogenesis in the testosterone plus estradiol-treated NBL rat model. Cancer Prev Res (Phila) 3, 371–380, 2010.
   PubMed Web of Science ®Google Scholar
• Bernoulli J, Yatkin E, Laakso A, Anttinen M, Bosland M, et al.: Histopathological evidence for an association of inflammation with ductal pin-like lesions but not with ductal adenocarcinoma in the prostate of the noble rat. Prostate 68, 728–739, 2008.
   PubMed Web of Science ®Google Scholar
• Tam NN, Leav I, and Ho SM: Sex hormones induce direct epithelial and inflammation-mediated oxidative/nitrosative stress that favors prostatic carcinogenesis in the noble rat. Am J Pathol 171, 1334–1341, 2007.
   PubMed Web of Science ®Google Scholar
• Ho SM, and Roy D: Sex hormone-induced nuclear DNA damage and lipid peroxidation in the dorsolateral prostates of Noble rats. Cancer Lett 84, 155–162, 1994.
   PubMed Web of Science ®Google Scholar
• Tam NN, Ghatak S, and Ho SM: Sex hormone-induced alterations in the activities of antioxidant enzymes and lipid peroxidation status in the prostate of Noble rats. Prostate 55, 1–8, 2003.
   PubMed Web of Science ®Google Scholar
• Cavalieri E, Frenkel K, Liehr JG, Rogan E, and Roy D: Estrogens as endogenous genotoxic agents—DNA adducts and mutations. J Natl Cancer Inst Monogr 75, 75–93, 2000.
   Google Scholar
• Han X, Liehr JG, and Bosland MC: Induction of a DNA adduct detectable by 32P-postlabeling in the dorsolateral prostate of NBL/Cr rats treated with estradiol-17 beta and testosterone. Carcinogenesis 16, 951–954, 1995.
   PubMed Web of Science ®Google Scholar
• Cavalieri EL, Devanesan P, Bosland MC, Badawi AF,and Rogan EG: Catechol estrogen metabolites and conjugates in different regions of the prostate of Noble rats treated with 4-hydroxyestradiol: implications for estrogen-induced initiation of prostate cancer. Carcinogenesis 23, 329–333, 2002.
   PubMed Web of Science ®Google Scholar
• Jefcoate CR, Liehr JG, Santen RJ, Sutter TR, Yager JD, et al.: Tissue-specific synthesis and oxidative metabolism of estrogens. J Natl Cancer Inst Monogr 75, 95–112, 2000.
   Google Scholar
• Bosland MC, Ford H, and Horton L: Induction at high incidence of ductal prostate adenocarcinomas in NBL/Cr and Sprague-Dawley Hsd:SD rats treated with a combination of testosterone and estradiol-17 beta or diethylstilbestrol. Carcinogenesis 16, 1311–1317, 1995.
   PubMed Web of Science ®Google Scholar
• Ofner P, Bosland MC, and Vena RL: Differential effects of diethylstilbestrol and estradiol-17 beta in combination with testosterone on rat prostate lobes. Toxicol Appl Pharmacol 112, 300–309, 1992.
   PubMed Web of Science ®Google Scholar
• Lippman SM, Goodman PJ, Klein EA, Parnes HL, Thompson IM, Jr., et al.: Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst 97, 94–102, 2005.
   PubMed Web of Science ®Google Scholar
• McCormick DL, Rao KV, Dooley L, Steele VE, Lubet RA, et al.: Influence of N-methyl-N-nitrosourea, testosterone, and N-(4-hydroxyphenyl)-all-trans-retinamide on prostate cancer induction in Wistar-Unilever rats. Cancer Res 58, 3282–3288, 1998.
   PubMed Web of Science ®Google Scholar
• Samuels BL, Murray JL, Cohen MB, Safa AR, Sinha BK, et al.: Increased glutathione peroxidase activity in a human sarcoma cell line with inherent doxorubicin resistance. Cancer Res 51, 521–527, 1991.
   PubMed Web of Science ®Google Scholar
• Oberley TD, Zhong W, Szweda LI, and Oberley LW: Localization of antioxidant enzymes and oxidative damage products in normal and malignant prostate epithelium. Prostate 44, 144–155, 2000.
   PubMed Web of Science ®Google Scholar
• Klein, EA, Thompson, IM, Jr., Tangen, CM, Crowley, JJ, Lucia, MS, et al.: Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 306, 1549–1556, 2011.
   PubMed Web of Science ®Google Scholar
• Zhong W, Yan T, Webber MM, and Oberley TD: Alteration of cellular phenotype and responses to oxidative stress by manganese superoxide dismutase and a superoxide dismutase mimic in RWPE-2 human prostate adenocarcinoma cells. Antioxid Redox Signal 6, 513–522, 2004.
   PubMed Web of Science ®Google Scholar
• Zachara BA, Szewczyk-Golec K, Tyloch J, Wolski Z, Szylberg T, et al.: Blood and tissue selenium concentrations and glutathione peroxidase activities in patients with prostate cancer and benign prostate hyperplasia. Neoplasma 52, 248–254, 2005.
   PubMed Web of Science ®Google Scholar
• Pinto RE and Bartley W: The nature of the sex-linked differences in glutathione peroxidase activity and aerobic oxidation of glutathione in male and female rat liver. Biochem J 115, 449–456, 1969.
   PubMed Web of Science ®Google Scholar
• Borras C, Gambini J, Gomez-Cabrera MC, Sastre J, Pallardo FV, et al.: 17beta-oestradiol up-regulates longevity-related, antioxidant enzyme expression via the ERK1 and ERK2[MAPK]/NFkappaB cascade. Aging Cell 4, 113–118, 2005.
   PubMed Web of Science ®Google Scholar
• Jackson MI and Combs GF, Jr.: Selenium and anticarcinogenesis: underlying mechanisms. Curr Opin Clin Nutr Metab Care 11, 718–726, 2008.
   PubMed Web of Science ®Google Scholar
• Waters DJ, Shen S, Kengeri SS, Chiang EC, Combs GF, Jr., et al.: Prostatic response to supranutritional selenium supplementation: comparison of the target tissue potency of selenomethionine vs. selenium-yeast on markers of prostatic homeostasis. Nutrients 4, 1650–1663, 2012.
   PubMed Web of Science ®Google Scholar